Analysis of long-term outcomes and causes influencing visual prognosis in eyes receiving anti-VEGF-A for wet age-related macular degeneration / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
; (12): 236-240, 2018.
Article
em Zh
| WPRIM
| ID: wpr-699723
Biblioteca responsável:
WPRO
ABSTRACT
As a progressive chronic disease,age-related macular degeneration (AMD) is the leading cause of blindness worldwide.However,current therapy for AM D shows a dramatic breakthrough.More and more patients with AMD undergo intravitreous injection of anti-vascular endothelial growth factor A (VEGF-A) regimen,which has been demonstrated a beneficial therapeutic treatment to improve visual acuity in a short period.The long-term outcomes have come into focus considering prolonged treatment cycle and follow-up period.The long-term outcomes and safety of anti VEGF-A will be reviewed in this article contributing to investigate the causes influencing prognosis of visual acuity after anti VEGF-A treatment.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Experimental Ophthalmology
Ano de publicação:
2018
Tipo de documento:
Article